Completado

Pharmacogenomics Study of Sleep Disturbance and Neurocognitive Impairments in the Opioid Addicts

0 criterios cumplidosConsulta de un vistazo cómo tu perfil cumple con cada criterio de elegibilidad.
Qué se está recopilando

Colección de datos

Recopilados desde hoy en adelante - Prospectivo
Muestra con ADN
Quiénes están siendo reclutados

Trastornos Relacionados con Narcóticos+1

+ Trastornos Mentales

+ Trastornos relacionados con los opioides

De 20 a 65 años
Ver todos los criterios de elegibilidad
Cómo está diseñado el estudio

Cohorte

Seguimiento de la incidencia de una enfermedad para identificar factores de riesgo y comprender su progresión a lo largo del tiempo.
Observacional
Inicio del estudio: marzo de 2009
Ver detalles del protocolo

Resumen

Patrocinador PrincipalNational Health Research Institutes, Taiwan
Última actualización: 9 de noviembre de 2016
Extraido de una base de datos validada por el gobierno.Reclamar como socio

Fecha de inicio: 1 de marzo de 2009

Fecha en la que se inscribió al primer participante.

Opioid abuse is a complex problem, which not only impacts on addicts' physical and psychological health individually, but also threats the society. Recently, spread of HIV via sexual behavior and needle sharing among injecting drug users (IDUs) also becomes a serious public health problem all over the world. In Taiwan, since the first HIV-infected IDU identified in 1987, the incident cases have mounted to 2,461 in 2005. To prevent the epidemics of HIV among IDUs, the Center for Disease Control (CDC) thus collaborated with Department of Justice and implemented harm reduction programs in 2005. It is the milestone that opioid addiction is officially treated as a health rather than a legal issue in Taiwan. Among the harm reduction programs of needle and syringe exchange for IDUs as well as substitution treatment for opioid dependence, methadone maintenance treatment (MMT) is one of the most important parts. Till 2008, there were over 13,000 heroin addicts participated in more than 80 MMT programs. Although the clinical evidences have proven the superior effectiveness of maintenance therapy in ameliorating illicit substances abuse, decreasing criminality and improving quality of life, there are common problems of sleep disturbance and neurocognitive impairments among the subjects receiving opioid medications. The concerns of the adverse effects might thus frustrate the subjects' motivation and compliance to maintain treatments. However, sleep disturbance and neurocognitive impairments related to opioid medications are often neglected in the clinical practices and there are scanty researches focusing on these crucial issues in the existing literature. In this prospective study, four groups of subjects including methadone maintenance treatment, buprenorphine/naloxone, medication-free opioid ex-addicts and healthy volunteers will be enrolled. Via the comprehensive assessments including clinical interview, neurocognitive examinations, electrocardiogram-based sleep breathing detector and pharmacogenomical evaluation, we will not only have the opportunities to have more insights on the impacts of opioid medications on sleep and neurocognitive performances, but also develop more adequate strategies to improve motivation and outcome in treating the opioid addicts.

Patrocinador PrincipalNational Health Research Institutes, Taiwan
Última actualización: 9 de noviembre de 2016
Extraido de una base de datos validada por el gobierno.Reclamar como socio

Protocolo

Esta sección proporciona detalles del plan del estudio, incluyendo cómo está diseñado y qué se está evaluando.
Detalles del Diseño

Se reclutarán 340 pacientes

Número total de participantes que el ensayo clínico espera reclutar.

Cohorte

Estos estudios siguen a un grupo de personas con características comunes (como una condición o año de nacimiento) durante un periodo específico para analizar resultados de salud o exposiciones.


Elegibilidad

Los investigadores buscan pacientes que cumplan ciertos criterios, conocidos como criterios de elegibilidad: estado general de salud o tratamientos previos.
Condiciones
Criterios

Cualquier sexo

Sexo biológico de los participantes elegibles para inscribirse.

De 20 a 65 años

Rango de edades de los participantes que pueden unirse al estudio.

Voluntarios sanos permitidos

Indica si personas sanas, sin la condición que se estudia, pueden participar.

Condiciones

Patología

Trastornos Relacionados con NarcóticosTrastornos MentalesTrastornos relacionados con los opioidesDependencia a la heroína

Criterios

Normal control group (NC): Inclusion criteria: Chinese ethnicity Men or women above age of 20 Able to participate in a clinical assessment in Chinese (including Mandarin and Taiwanese dialects) Individuals who have completed a written consent form Exclusion criteria: Patients with comorbid severe mental disorders including: Organic mental disorders, or Schizophrenia Past diagnosis of Heroin dependence by DSM-IV definition Severe cognitive impairment Being pregnant Methadone maintenance treatment group (MMT) Inclusion criteria: Chinese ethnicity Men or women above age of 20, below age of 65 Able to participate in a clinical assessment in Chinese (including Mandarin and Taiwanese dialects) Diagnosis of Heroin dependence by DSM-IV definition Enter methadone maintenance therapy for at least 3 months No change of methadone dosage for the last week Regularly took methadone for the last week Individuals who have completed a written consent form Exclusion criteria: Patients with comorbid severe mental disorders including: Organic mental disorders, or Schizophrenia Severe cognitive impairment Being pregnant Buprenorphine/Naloxone treatment group (BNT) Inclusion criteria: Chinese ethnicity Men or women above age of 20, below age of 65 Able to participate in a clinical assessment in Chinese (including Mandarin and Taiwanese dialects) Diagnosis of Heroin dependence by DSM-IV definition Enter buprenorphine maintenance therapy for at least 3 months No change of buprenorphine dosage for the last week Regularly took buprenorphine for the last week Individuals who have completed a written consent form Exclusion criteria: Patients with comorbid severe mental disorders including: Organic mental disorders, or Schizophrenia Severe cognitive impairment Being pregnant Medication-free ex-addict group (MF) Inclusion criteria: Chinese ethnicity Men or women above age of 20 Able to participate in a clinical assessment in Chinese (including Mandarin and Taiwanese dialects) Diagnosis of Heroin dependence by DSM-IV definition Individuals who have completed a written consent form Exclusion criteria: Patients with comorbid severe mental disorders including: Organic mental disorders, or Schizophrenia Severe cognitive impairment Being pregnant Exposure of methadone, buprenorphine and other opioid treatment in the previous 3 months

Plan de Estudio

Conoce todos los tratamientos administrados en este estudio, su descripción detallada y en qué consisten.
Grupos de Tratamiento
Objetivos del Estudio

4 grupos de intervención están designados en este estudio

0% de probabilidad de ser asignado al grupo placebo

Grupos de Tratamiento

Objetivos del Estudio

Objetivos Primarios

Objetivos Secundarios

Centros del Estudio

Estos son los hospitales, clínicas o centros de investigación donde se lleva a cabo el estudio. Puedes encontrar la ubicación más cercana a ti y su estado de reclutamiento.

Este estudio tiene 5 ubicaciones

ChangHua Christian Hospital

Lukang, TaiwanAbrir ChangHua Christian Hospital en Google Maps

Far Eastern Memorial Hospital

Banqiao District, Taiwan

Far Eastern Memorial Hospital

Banqiao District, Taiwan

En-Chu-Gong Hospital

Sanxia District, Taiwan
Completado5 Centros de Estudio